Cargando…

Cardiovascular disease risk profiles in inflammatory joint disease entities

BACKGROUND: Patients with inflammatory joint diseases (IJD) have increased risk of cardiovascular disease (CVD). Our aim was to compare CVD risk profiles in patients with IJD, including rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) and evaluate the future r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wibetoe, Grunde, Ikdahl, Eirik, Rollefstad, Silvia, Olsen, Inge C., Bergsmark, Kjetil, Kvien, Tore K., Salberg, Anne, Soldal, Dag Magnar, Bakland, Gunnstein, Lexberg, Åse, Fevang, Bjørg-Tilde, Gulseth, Hans Christian, Haugeberg, Glenn, Semb, Anne Grete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496163/
https://www.ncbi.nlm.nih.gov/pubmed/28673314
http://dx.doi.org/10.1186/s13075-017-1358-1
_version_ 1783247915804786688
author Wibetoe, Grunde
Ikdahl, Eirik
Rollefstad, Silvia
Olsen, Inge C.
Bergsmark, Kjetil
Kvien, Tore K.
Salberg, Anne
Soldal, Dag Magnar
Bakland, Gunnstein
Lexberg, Åse
Fevang, Bjørg-Tilde
Gulseth, Hans Christian
Haugeberg, Glenn
Semb, Anne Grete
author_facet Wibetoe, Grunde
Ikdahl, Eirik
Rollefstad, Silvia
Olsen, Inge C.
Bergsmark, Kjetil
Kvien, Tore K.
Salberg, Anne
Soldal, Dag Magnar
Bakland, Gunnstein
Lexberg, Åse
Fevang, Bjørg-Tilde
Gulseth, Hans Christian
Haugeberg, Glenn
Semb, Anne Grete
author_sort Wibetoe, Grunde
collection PubMed
description BACKGROUND: Patients with inflammatory joint diseases (IJD) have increased risk of cardiovascular disease (CVD). Our aim was to compare CVD risk profiles in patients with IJD, including rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) and evaluate the future risk of CVD. METHODS: The prevalence and numbers of major CVD risk factors (CVD-RFs) (hypertension, elevated cholesterol, obesity, smoking, and diabetes mellitus) were estimated in patients with RA, axSpA and PsA. Relative and absolute risk of CVD according to Systematic Coronary Risk Evaluation (SCORE) was calculated. RESULTS: In total, 3791 patients were included. CVD was present in 274 patients (7.2%). Of those without established CVD; hypertension and elevated cholesterol were the most frequent CVD-RFs, occurring in 49.8% and 32.8% of patients. Patients with PsA were more often hypertensive and obese. Overall, 73.6% of patients had a minimum of one CVD-RF, which increased from 53.2% among patients aged 30 to <45 years, to 86.2% of patients aged 60 to ≤80 years. Most patients (93.5%) had low/moderate estimated risk of CVD according to SCORE. According to relative risk estimations, 35.2% and 24.7% of patients had two or three times risk or higher, respectively, compared to individuals with no CVD-RFs. CONCLUSIONS: In this nationwide Norwegian project, we have shown for the first time that prevalence and numbers of CVD-RFs were relatively comparable across the three major IJD entities. Furthermore, estimated absolute CVD risk was low, but the relative risk of CVD was markedly high in patients with IJD. Our findings indicate the need for CVD risk assessment in all patients with IJD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1358-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5496163
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54961632017-07-05 Cardiovascular disease risk profiles in inflammatory joint disease entities Wibetoe, Grunde Ikdahl, Eirik Rollefstad, Silvia Olsen, Inge C. Bergsmark, Kjetil Kvien, Tore K. Salberg, Anne Soldal, Dag Magnar Bakland, Gunnstein Lexberg, Åse Fevang, Bjørg-Tilde Gulseth, Hans Christian Haugeberg, Glenn Semb, Anne Grete Arthritis Res Ther Research Article BACKGROUND: Patients with inflammatory joint diseases (IJD) have increased risk of cardiovascular disease (CVD). Our aim was to compare CVD risk profiles in patients with IJD, including rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) and evaluate the future risk of CVD. METHODS: The prevalence and numbers of major CVD risk factors (CVD-RFs) (hypertension, elevated cholesterol, obesity, smoking, and diabetes mellitus) were estimated in patients with RA, axSpA and PsA. Relative and absolute risk of CVD according to Systematic Coronary Risk Evaluation (SCORE) was calculated. RESULTS: In total, 3791 patients were included. CVD was present in 274 patients (7.2%). Of those without established CVD; hypertension and elevated cholesterol were the most frequent CVD-RFs, occurring in 49.8% and 32.8% of patients. Patients with PsA were more often hypertensive and obese. Overall, 73.6% of patients had a minimum of one CVD-RF, which increased from 53.2% among patients aged 30 to <45 years, to 86.2% of patients aged 60 to ≤80 years. Most patients (93.5%) had low/moderate estimated risk of CVD according to SCORE. According to relative risk estimations, 35.2% and 24.7% of patients had two or three times risk or higher, respectively, compared to individuals with no CVD-RFs. CONCLUSIONS: In this nationwide Norwegian project, we have shown for the first time that prevalence and numbers of CVD-RFs were relatively comparable across the three major IJD entities. Furthermore, estimated absolute CVD risk was low, but the relative risk of CVD was markedly high in patients with IJD. Our findings indicate the need for CVD risk assessment in all patients with IJD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1358-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-07-03 2017 /pmc/articles/PMC5496163/ /pubmed/28673314 http://dx.doi.org/10.1186/s13075-017-1358-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wibetoe, Grunde
Ikdahl, Eirik
Rollefstad, Silvia
Olsen, Inge C.
Bergsmark, Kjetil
Kvien, Tore K.
Salberg, Anne
Soldal, Dag Magnar
Bakland, Gunnstein
Lexberg, Åse
Fevang, Bjørg-Tilde
Gulseth, Hans Christian
Haugeberg, Glenn
Semb, Anne Grete
Cardiovascular disease risk profiles in inflammatory joint disease entities
title Cardiovascular disease risk profiles in inflammatory joint disease entities
title_full Cardiovascular disease risk profiles in inflammatory joint disease entities
title_fullStr Cardiovascular disease risk profiles in inflammatory joint disease entities
title_full_unstemmed Cardiovascular disease risk profiles in inflammatory joint disease entities
title_short Cardiovascular disease risk profiles in inflammatory joint disease entities
title_sort cardiovascular disease risk profiles in inflammatory joint disease entities
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496163/
https://www.ncbi.nlm.nih.gov/pubmed/28673314
http://dx.doi.org/10.1186/s13075-017-1358-1
work_keys_str_mv AT wibetoegrunde cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities
AT ikdahleirik cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities
AT rollefstadsilvia cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities
AT olseningec cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities
AT bergsmarkkjetil cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities
AT kvientorek cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities
AT salberganne cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities
AT soldaldagmagnar cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities
AT baklandgunnstein cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities
AT lexbergase cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities
AT fevangbjørgtilde cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities
AT gulsethhanschristian cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities
AT haugebergglenn cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities
AT sembannegrete cardiovasculardiseaseriskprofilesininflammatoryjointdiseaseentities